Furthermore, soluble form of DPP4 (sDPP4) was found to be decreased in COVID‐19 patients,84 potentially making them susceptible to infection as it was shown that sDPP4 in the bloodstream could bind and sequester the virus and prevent it from attacking host cells.85 Here, DPP4 is linked to COVID-19.